TY - JOUR
T1 - Kappa-opioid receptor-mediated effects of the plant-derived hallucinogen, salvinorin A, on inverted screen performance in the mouse
AU - Fantegrossi, William E.
AU - Kugle, Kelly M.
AU - Valdes, Leander J.
AU - Koreeda, Masato
AU - Woods, James H.
N1 - Copyright:
Copyright 2017 Elsevier B.V., All rights reserved.
PY - 2005/12
Y1 - 2005/12
N2 - Salvinorin A is a pharmacologically active diterpene that occurs naturally in the Mexican mint Ska Maria Pastora (Salvia divinorum) and represents the first naturally occurring κ-opioid receptor agonist. The chemical structure of salvinorin A is novel among the opioids, and thus defines a new structural class of κ-opioid-receptor selective drugs. Few studies have examined the effects of salvinorin A in vivo, and fewer still have attempted to assess the agonist actions of this compound at μ-opioid, δ-opioid, and κ-opioid receptors using selective antagonists. In the mouse, salvinorin A disrupted climbing behavior on an inverted screen task, indicating a rapid, but short-lived induction of sedation/motor incoordination. Similar effects were observed with the μ-agonist remifentanil and the synthetic κ-agonist U69,593. When behaviorally equivalent doses of all three opioids were challenged with antagonists at doses selective for μ-opioid, δ-opioid, or κ-opioid receptors, results suggested that the motoric effects of remifentanil were mediated by μ-receptors, whereas those of salvinorin A and U69,593 were mediated via κ-receptors. Despite similar potencies and degrees of effectiveness, salvinorin A and U69,593 differed with regard to their susceptibility to antagonism by the κ-antagonist nor-binaltorphamine. This later finding, coupled with the novel chemical structure of the compound, is consistent with recent findings that the diterpene salvinorin A may bind to the κ-receptor in a manner that is qualitatively different from that of more traditional κ-agonists such as the benzeneacetamide U69,593. Such pharmacological differences among these κ-opioids raise the possibility that the development of other diterpene-based opioids may yield important therapeutic compounds.
AB - Salvinorin A is a pharmacologically active diterpene that occurs naturally in the Mexican mint Ska Maria Pastora (Salvia divinorum) and represents the first naturally occurring κ-opioid receptor agonist. The chemical structure of salvinorin A is novel among the opioids, and thus defines a new structural class of κ-opioid-receptor selective drugs. Few studies have examined the effects of salvinorin A in vivo, and fewer still have attempted to assess the agonist actions of this compound at μ-opioid, δ-opioid, and κ-opioid receptors using selective antagonists. In the mouse, salvinorin A disrupted climbing behavior on an inverted screen task, indicating a rapid, but short-lived induction of sedation/motor incoordination. Similar effects were observed with the μ-agonist remifentanil and the synthetic κ-agonist U69,593. When behaviorally equivalent doses of all three opioids were challenged with antagonists at doses selective for μ-opioid, δ-opioid, or κ-opioid receptors, results suggested that the motoric effects of remifentanil were mediated by μ-receptors, whereas those of salvinorin A and U69,593 were mediated via κ-receptors. Despite similar potencies and degrees of effectiveness, salvinorin A and U69,593 differed with regard to their susceptibility to antagonism by the κ-antagonist nor-binaltorphamine. This later finding, coupled with the novel chemical structure of the compound, is consistent with recent findings that the diterpene salvinorin A may bind to the κ-receptor in a manner that is qualitatively different from that of more traditional κ-agonists such as the benzeneacetamide U69,593. Such pharmacological differences among these κ-opioids raise the possibility that the development of other diterpene-based opioids may yield important therapeutic compounds.
KW - Hallucinogens
KW - Inverted screen test
KW - Mouse
KW - Opioid receptors
KW - Salvinorin A
UR - http://www.scopus.com/inward/record.url?scp=27944491908&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=27944491908&partnerID=8YFLogxK
U2 - 10.1097/00008877-200512000-00005
DO - 10.1097/00008877-200512000-00005
M3 - Article
C2 - 16286814
AN - SCOPUS:27944491908
SN - 0955-8810
VL - 16
SP - 627
EP - 633
JO - Behavioural Pharmacology
JF - Behavioural Pharmacology
IS - 8
ER -